Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Belot

Showing results (111-120 of 250) with videos related to

Pageof 25
Sort By:
Plos One|September 21, 2017
Isolated positive anti-SS-B autoantibodies are not related to clinical features of systemic autoimmune diseases: Results from a routine population surveySabine Jardel, Nicole Fabien, Arnaud Hot, et al.
Clinical & Translational Immunology|August 25, 2021
Antibodies against type I interferon: detection and association with severe clinical outcome in COVID-19 patientsDavid Goncalves, Mehdi Mezidi, Paul Bastard, et al.
European Journal of Immunology|December 14, 2020
Type-I Interferon assessment in 45 minutes using the FilmArray<sup>®</sup> PCR platform in SARS-CoV-2 and other viral infectionsMarine Mommert, Magali Perret, Matthew Hockin, et al.
Kidney International Reports|August 24, 2019
COPA Syndrome as a Cause of Lupus NephritisSiham Boulisfane-El Khalifi, Sebastien Viel, Annie Lahoche, et al.
Journal of Clinical Medicine|October 13, 2021
NLRC4 GOF Mutations, a Challenging Diagnosis from Neonatal Age to AdulthoodJuliette Bardet, Noémie Laverdure, Mathieu Fusaro, et al.
Rheumatology International|September 24, 2024
Diagnostic delays in familial Mediterranean fever: a Juvenile Inflammatory Rheumatism (JIR) cohort studyRim Bourguiba, Samuel Deshayes, Gayane Amaryan, et al.
Joint Bone Spine|October 3, 2017
Building a transitional care checklist in rheumatology: A Delphi-like surveyChristina Akre, Joan-Carles Suris, Alexandre Belot, et al.
Pediatrics|June 28, 2023
Immunomodulatory Therapy for MIS-CNaïm Ouldali, Mary Beth F Son, Andrew J McArdle, et al.
Chest|September 11, 2016
Severe Pulmonary Fibrosis as the First Manifestation of Interferonopathy (TMEM173 Mutation)Cécile Picard, Guillaume Thouvenin, Caroline Kannengiesser, et al.
Journal of Clinical Immunology|June 14, 2022
An Immunological Axis Involving Interleukin 1β and Leucine-Rich-α2-Glycoprotein Reflects Therapeutic Response of Children with Kawasaki Disease: Implications from the KAWAKINRA TrialChristoph Kessel, Isabelle Koné-Paut, Stéphanie Tellier, et al.
Pageof 25

Showing results (111-120 of 250) with videos related to

Sort By:
Pageof 25
Plos One|September 21, 2017
Isolated positive anti-SS-B autoantibodies are not related to clinical features of systemic autoimmune diseases: Results from a routine population surveySabine Jardel, Nicole Fabien, Arnaud Hot, et al.
Clinical & Translational Immunology|August 25, 2021
Antibodies against type I interferon: detection and association with severe clinical outcome in COVID-19 patientsDavid Goncalves, Mehdi Mezidi, Paul Bastard, et al.
European Journal of Immunology|December 14, 2020
Type-I Interferon assessment in 45 minutes using the FilmArray<sup>®</sup> PCR platform in SARS-CoV-2 and other viral infectionsMarine Mommert, Magali Perret, Matthew Hockin, et al.
Kidney International Reports|August 24, 2019
COPA Syndrome as a Cause of Lupus NephritisSiham Boulisfane-El Khalifi, Sebastien Viel, Annie Lahoche, et al.
Journal of Clinical Medicine|October 13, 2021
NLRC4 GOF Mutations, a Challenging Diagnosis from Neonatal Age to AdulthoodJuliette Bardet, Noémie Laverdure, Mathieu Fusaro, et al.
Rheumatology International|September 24, 2024
Diagnostic delays in familial Mediterranean fever: a Juvenile Inflammatory Rheumatism (JIR) cohort studyRim Bourguiba, Samuel Deshayes, Gayane Amaryan, et al.
Joint Bone Spine|October 3, 2017
Building a transitional care checklist in rheumatology: A Delphi-like surveyChristina Akre, Joan-Carles Suris, Alexandre Belot, et al.
Pediatrics|June 28, 2023
Immunomodulatory Therapy for MIS-CNaïm Ouldali, Mary Beth F Son, Andrew J McArdle, et al.
Chest|September 11, 2016
Severe Pulmonary Fibrosis as the First Manifestation of Interferonopathy (TMEM173 Mutation)Cécile Picard, Guillaume Thouvenin, Caroline Kannengiesser, et al.
Journal of Clinical Immunology|June 14, 2022
An Immunological Axis Involving Interleukin 1β and Leucine-Rich-α2-Glycoprotein Reflects Therapeutic Response of Children with Kawasaki Disease: Implications from the KAWAKINRA TrialChristoph Kessel, Isabelle Koné-Paut, Stéphanie Tellier, et al.
Pageof 25